Financial news in brief: Avecho CBD trial latest; Argent’s milestone delivery – Cannabiz
Pharmaceutical CBD clinical trial development represents important progress in cannabis therapeutics, though patients should maintain realistic expectations about timing and superiority over current protocols. Understanding the distinction between…
Drug Development, Tax Breaks, Future Reimbursement Expected After Medical Marijuana …
Federal policy changes around cannabis drug development tax incentives could reshape medical cannabis access and research funding. Understanding these regulatory shifts helps clinicians prepare for evolving therapeutic landscapes while maintaining focus…
Selective TRPV2 Antagonists Derived from the Natural Product Piperlongumine Inhibit Cancer Cell Migration and Metastasis.
Researchers developed HKC54, a selective TRPV2 antagonist that inhibits cancer cell migration in laboratory studies. This TRPV2 antagonist cancer cell migration research represents early-stage drug development that could eventually lead to new…
Trump moves to reschedule marijuana – POLITICO
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyFederal RegulationMedical…
DOJ Expected to Ease Marijuana Controls as Soon as Wed. – YouTube
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyResearchFederal RegulationClinical…
Selective TRPV2 Antagonists Derived from Piperlongumine Inhibit Cancer Cell Migration and Metastasis
Selective TRPV2 antagonists are emerging as important tools in cancer metastasis and pain research. Derived from the natural product piperlongumine, these antagonists offer improved selectivity over cannabidiol. This research advances understanding of…
Chinese Researchers Develop Cannabis-Based Molecule with Strong Pain Relief, Fewer Side Effects
Synthetic cannabinoid development is a promising area for pain relief with fewer side effects. Chinese researchers have created a novel cannabis-based molecule showing strong analgesic potential. This development could expand treatment options for…
CBC–RIS Partnership Signals AI-Led Transformation for Healthcare and Pharma: Experts
The CBC-RIS partnership highlights the rise of ai clinical decision support in healthcare and pharma. This technology is crucial for advancing cannabis medicine by improving dosing protocols. AI clinical decision support promises to enhance…
Forge Genetics Announces Licensing Deal to Explore Forge Editing in Pharmaceutical Uses
Forge Genetics has announced a licensing deal to explore gene editing pharmaceutical applications. This emerging technology could influence cannabis-based medicines in the future. The clinical relevance remains to be determined as research progresses.
Avicanna Announces Changes to its Board of Directors – FirstWord Pharma
Board changes cannabis pharmaceutical companies can indicate strategic shifts in clinical research and regulatory approaches. Avicanna recently announced updates to its board of directors. These changes may influence the development of cannabinoid-based…